First Report of Outcomes in the TRILUMINATE Pivotal Clinical Trial in Patients With Severe Tricuspid Regurgitation

Within the last 24 months, I have financial relationship(s) or affiliation(s) with a manufacturer, marketer, reseller, or distributor of a healthcare product or service involved in the management of patients with any cardiovascular disease to include devices, drugs, and digital health care products listed below:

• Royalty/Intellectual Property Rights (Both) - Edwards Lifesciences; Medtronic
• Grant Support/Research Contract (Institutional) - Medtronic; NeoChord; Abbott Vascular